Enanta Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 124k | 11.97 |
| 2025-03-31 | $741k | 134k | 5.52 |
| 2024-12-31 | $938k | 163k | 5.75 |
| 2024-09-30 | $2.5M | 244k | 10.36 |
| 2024-06-30 | $2.1M | 159k | 12.97 |
| 2024-03-31 | $2.4M | 138k | 17.46 |
| 2023-12-31 | $1.4M | 151k | 9.41 |
| 2023-09-30 | $2.2M | 197k | 11.17 |
| 2023-06-30 | $3.9M | 183k | 21.40 |
| 2023-03-31 | $14M | 142k | 97.35 |
| 2022-12-31 | $8.4M | 182k | 46.52 |
| 2022-06-30 | $8.4M | 178k | 47.27 |
| 2022-03-31 | $2.8M | 40k | 71.15 |
| 2021-12-31 | $0 | 37k | 0.00 |
| 2021-03-31 | $1.9M | 39k | 49.33 |
| 2020-12-31 | $1.9M | 44k | 42.10 |
| 2020-09-30 | $2.1M | 46k | 44.80 |
| 2020-06-30 | $2.4M | 47k | 50.22 |
| 2020-03-31 | $2.4M | 47k | 51.42 |
| 2019-12-31 | $3.6M | 56k | 63.06 |
| 2019-09-30 | $3.6M | 61k | 59.06 |
| 2019-06-30 | $9.1M | 109k | 83.76 |
| 2019-03-31 | $5.5M | 57k | 95.38 |
| 2018-12-31 | $5.5M | 78k | 71.03 |
| 2018-09-30 | $4.7M | 55k | 85.47 |
| 2018-06-30 | $7.9M | 69k | 115.90 |
| 2018-03-31 | $8.2M | 102k | 80.79 |
| 2017-12-31 | $9.8M | 166k | 58.67 |
| 2017-06-30 | $5.0M | 139k | 35.98 |
| 2017-03-31 | $3.4M | 111k | 30.80 |
| 2016-12-31 | $4.6M | 138k | 33.51 |
| 2016-09-30 | $3.7M | 139k | 26.61 |
| 2016-06-30 | $4.0k | 190 | 21.05 |
| 2016-03-31 | $12k | 414 | 28.99 |
| 2015-03-31 | $1.4M | 46k | 30.61 |